Lead sponsor
Shanghai Jiao Tong University School of Medicine
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
2
Trials led
1
Ongoing
92
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
2
Trials by status
Not yet recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DMBMI 30-45not applicableCompleted62
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMBMI 30-45not applicableNot yet recruiting30